Glucagon-like peptide-1 analogs with long duration of action
US7538185B2 · kind B2 · utility
0Cited by
2References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 7, 2005 |
| Grant date | May 26, 2009 |
| Priority date | — |
| Expiry date | Jun 17, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P5/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel GLP-1 analogs having improved biological potency as well as extended pharmacological activity are described herein. More specifically, the present invention relates to GLP-1 analogs (28 or 29 aa long) comprising amino acid substitutions at one or more of the following positions: 8, 20, 27, 30 and 33.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.